Methods and compositions for treating pulmonary disorders using

Details Methods and compositions for treating pulmonary disorders using Methods and compositions for treating pulmonary disorders using

1996-03-07

1998-08-18

Phelan, D. Gabrielle

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

424436, 424447, 424451, 424464, 514630, A61L 904

Patent

active

057955646

ABSTRACT:
A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased bronchial distribution when administered by inhalation.

REFERENCES:
patent: 3994974 (1976-11-01), Murakami et al.
patent: 4380534 (1983-04-01), Fukui
patent: 4814161 (1989-03-01), Jinks
patent: 4917676 (1990-04-01), Heiber
patent: 4975466 (1990-12-01), Bottcher
patent: 5135954 (1992-08-01), McDonald
The Merck Index, S. Budavari, ed. 11th edition, pp. 4159-4160, 1989.
"Comparison of the Action of BD 40 A and some Other .beta.-Adrenoceptor Stimulants of the Isolated Trachea and Atria of the Guinea Pig" H. Ida Arzneim.-Forsch. 26, 839-842 (1976).
"Cardiorespiratory Activities of 3-Formylamino-4-hydroxy .alpha.-(N-1-methyl-2-methoxyphenethylaminomethyl)-benzylalcohol-bemifumar ate (BD 40A) and some other .beta.-Adrenoceptor Stimulants in Conscious Guinea Pigs" H. Ida Arzneim.-Forsch. 26, 1337-1340 (1976).
"New .beta.-Adrenoreceptor Stimulants. Studies on 3-Acylamino-4-hydroxy-.alpha.-(N-substituted aminomethyl)benzyl Alcohols" Murase et al. Chem. Pharm. Bull. 25(6) 1368-1377 (1977).
"Steric Aspects of Agonism and Antagonism at .beta.-Adrenoceptors: Synthesis of and Pharmacological Experiments With the Enantiomers of Formoterol and Their Diasteromers" Trofast et al. Chirality 3 443-450 (1991).
"A Three-Month Comparison of Twice Daily Inhaled Formoterol Versus Four Times Daily Inhaled Albuterol in the Management of Stable Asthma.sup.1-3 " Kesten et al. Am. Rev. Respir. Dis. 144 622-625 (1991).
"Absolute Configurations of Four Isomers of 3-Formamido-4-hydroxy-. . . " Murase et al. Chem. Pharm. Bull. 26, 1123-29 (1978).
".beta.-Adrenoceptor Ligands: Characterization and Quantification of Drug Effects" Lemoine Quant. Struct. -Act. Relat. 11. 211-218 (1992).
"Stereoselectivity in pharmacodynamics and pharmacokinetics" Ariens Schjweiz. med. Wochenschr. 120, 131-134 (1990).
"Racemic therapeutics-ethical and regulatory aspects" Ariens Eur. J. Clin. Pharmacol 41, 89-93 (1991).
"Racemates Versus Enantiomers in Drug Development: Dogmatism . . . " Testa et al. Chirality 2, 129-133 (1990).
Murase et al. "Absolute Configurations of Four Isomers of 3-Formamido-4-hydroxy-. . . " Chem. Pharm. Bull. 26, 1123-1129 (1978).
Horst Lemoine ".beta.-Adrenoceptor Ligands: Characterization and Quantification of Drug Effects" Quant. Struct. -Act. Relat. 11, 211-218 (1992).
E.J. Ariens, "Racemische therapeutica probleemmiddelen" Pharmaceutisch Weekblad, 125, 552-554 (1990).
E.J. Ariens, "Stereoselectivity in Pharmacodynamics and Pharmacokinetics" Schweiz. Med. Wochenschr, 120; 131-134, (1990).
E.J. Ariens, Racemic Therapeutics-Ethical and Regulatory Aspects,Eur. J. Clin. Pharmacol, 41, 89-93, (1991).
Testa, Bernard and Trager, William, "Racemates Versus Enantiomers in Drugs Development: Dogmatism or Pragmatism?" Chirality, 2, 129-133, (1990).

Affiliated with

Also associated with

Rating

Methods and compositions for treating pulmonary disorders using does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treating pulmonary disorders using , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating pulmonary disorders using will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1112450